Literature DB >> 28770361

Exploring the binding energy profiles of full agonists, partial agonists, and antagonists of the α7 nicotinic acetylcholine receptor.

Nargis Tabassum1,2, Qianyun Ma1,2, Guanzhao Wu1,2, Tao Jiang1,2, Rilei Yu3,4.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) belong to the Cys-loop receptor family and are important drug targets for the treatment of neurological diseases. However, the precise determinants of the binding efficacies of ligands for these receptors are unclear. Therefore, in this study, the binding energy profiles of various ligands (full agonists, partial agonists, and antagonists) were quantified by docking those ligands with structural ensembles of the α7 nAChR exhibiting different degrees of C-loop closure. This approximate treatment of interactions suggested that full agonists, partial agonists, and antagonists of the α7 nAChR possess distinctive binding energy profiles. Results from docking revealed that ligand binding efficacy may be related to the capacity of the ligand to stabilize conformational states with a closed C loop.

Entities:  

Keywords:  Docking; Molecular dynamic simulations; Nicotinic acetylcholine receptor; Umbrella sampling

Mesh:

Substances:

Year:  2017        PMID: 28770361     DOI: 10.1007/s00894-017-3419-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

1.  Modeling differential binding of alpha4beta2 nicotinic acetylcholine receptor with agonists and antagonists.

Authors:  Xiaoqin Huang; Fang Zheng; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2008-12-10       Impact factor: 15.419

2.  Molecular simulation study of the unbinding of α-conotoxin [ϒ4E]GID at the α7 and α4β2 neuronal nicotinic acetylcholine receptors.

Authors:  Abishek Suresh; Andrew Hung
Journal:  J Mol Graph Model       Date:  2016-09-21       Impact factor: 2.518

3.  Progress towards the development of animal models of smoking-related behaviors.

Authors:  A C Collins; M J Marks
Journal:  J Addict Dis       Date:  1991

4.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.

Authors:  Scott B Hansen; Gerlind Sulzenbacher; Tom Huxford; Pascale Marchot; Palmer Taylor; Yves Bourne
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

Review 5.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

Review 6.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

Review 7.  Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.

Authors:  Stephen P Arneric; Mark Holladay; Michael Williams
Journal:  Biochem Pharmacol       Date:  2007-06-26       Impact factor: 5.858

8.  A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptors.

Authors:  Marijke Brams; Anshul Pandya; Dmitry Kuzmin; René van Elk; Liz Krijnen; Jerrel L Yakel; Victor Tsetlin; August B Smit; Chris Ulens
Journal:  PLoS Biol       Date:  2011-03-29       Impact factor: 8.029

9.  Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.

Authors:  Radovan Spurny; Sarah Debaveye; Ana Farinha; Ken Veys; Ann M Vos; Thomas Gossas; John Atack; Sonia Bertrand; Daniel Bertrand; U Helena Danielson; Gary Tresadern; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  X-ray structure of the human α4β2 nicotinic receptor.

Authors:  Claudio L Morales-Perez; Colleen M Noviello; Ryan E Hibbs
Journal:  Nature       Date:  2016-10-03       Impact factor: 49.962

View more
  3 in total

1.  Molecular dynamics simulations of dihydro-β-erythroidine bound to the human α4β2 nicotinic acetylcholine receptor.

Authors:  Rilei Yu; Han-Shen Tae; Qingliang Xu; David J Craik; David J Adams; Tao Jiang; Quentin Kaas
Journal:  Br J Pharmacol       Date:  2019-06-07       Impact factor: 8.739

2.  Discovery of fragments inducing conformational effects in dynamic proteins using a second-harmonic generation biosensor.

Authors:  Edward A FitzGerald; Margaret T Butko; Pierre Boronat; Daniela Cederfelt; Mia Abramsson; Hildur Ludviksdottir; Jacqueline E van Muijlwijk-Koezen; Iwan J P de Esch; Doreen Dobritzsch; Tracy Young; U Helena Danielson
Journal:  RSC Adv       Date:  2021-02-17       Impact factor: 3.361

Review 3.  In Silico Modeling of the α7 Nicotinic Acetylcholine Receptor: New Pharmacological Challenges Associated with Multiple Modes of Signaling.

Authors:  Alican Gulsevin; Roger L Papke; Nicole Horenstein
Journal:  Mini Rev Med Chem       Date:  2020       Impact factor: 3.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.